Effects of retinoids in mouse models of colitis: Benefit or danger to the gastrointestinal tract

Inflammatory Bowel Diseases

Volumn 19, Issue 11, 2013, Pages 2356-2365

  Frey Wagner, Isabelle ^a   Fischbeck, Anne ^a   Cee, Alexandra ^a   Leonardi, Irina ^a   Gruber, Sven ^a   Becker, Eugenia ^a   Atrott, Kirstin ^a   Lang, Silvia ^a   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Dextran sulphate sodium; Inflammatory bowel disease; Retinoid; T cell transfer colitis

Indexed keywords

4 OXOISOTRETINOIN; DEXTRAN SULFATE; INTERLEUKIN 12; ISOTRETINOIN; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CD4+ CD25+ T LYMPHOCYTE; CELL TRANSFER; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; CYTOKINES; DERMATOLOGIC AGENTS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL TRACT; ISOTRETINOIN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; PEROXIDASE; T-LYMPHOCYTES, REGULATORY;

EID: 84888258873     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31829cf1fc     Document Type: Article

References (31)

1. Crockett SD, Gulati A, Sandler RS, et al. A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol. 2009;104:2387-2393.
2. Shale M, Kaplan GG, Panaccione R, et al. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut. 2009;58:737-741.
3. Passier JL, Srivastava N, van Puijenbroek EP. Isotretinoin-induced inflammatory bowel disease. Neth J Med. 2006;64:52A4.
4. Martin P, Manley PN, Depew WT, et al. Isotretinoin-associated proctosigmoiditis. Gastroenterology. 1987;93:606-609.
5. Etminan M, Bird ST, Delaney JA, et al. Isotretinoin and risk for inflammatory bowel disease: A nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol. 2013;149:216-220.
6. Reifen R, Nur T, Ghebermeskel K, et al. Vitamin A deficiency exacerbates inflammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation. J Nutr. 2002;132:2743-2747.
7. Benson MJ, Pino-Lagos K, Rosemblatt M, et al. All-trans retinoic acid mediates enhanced Treg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med. 2007;204:1765-1774.
8. Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 2007; 28:551-558.
9. Nikoopour E, Schwartz JA, Singh B. Therapeutic benefits of regulating inflammation in autoimmunity. Inflamm Allergy Drug Targets. 2008;7: 203-210.
10. Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86:959-969.
11. Hall JA, Grainger JR, Spencer SP, et al. The role of retinoic acid in tolerance and immunity. Immunity. 2011;35:13-22.
12. Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:180-186.
13. Iwata M, Yokota A. Retinoic acid production by intestinal dendritic cells. Vitam Horm. 2011;86:127-152.
14. Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol. 2012;12:696-708.
15. Osanai M, Nishikiori N, Murata M, et al. Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. Mol Pharmacol. 2007;71:250-258.
16. Oehlers SH, Vega Flores M, Hall CJ, et al. Retinoic acid suppresses intestinal mucus production and exacerbates experimental colitis. Dis Model Mech. 2012;5:457-467.
17. Bai A, Lu N, Zeng H, et al. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile. J Interferon Cytokine Res. 2010;30:399-406.
18. Desreumaux P, Dubuquoy L, Nutten S, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor g (PPARg) heterodimer: A basis for new therapeutic strategies. J Exp Med. 2001;193:827-838.
19. Collins CB, Aherne CM, Kominsky D, et al. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology. 2011;141:1821-1831.
20. Westendorf AM, Templin M, Geffers R, et al. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut. 2005;54:60-69.
21. Menning A, Loddenkemper C, Westendorf AM, et al. Retinoic acidinduced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation. Eur J Immunol. 2010;40:2539-2548.
22. Wada Y, Hisamatsu T, Kamada N, et al. Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells. Inflamm Bowel Dis. 2009;15:1548-1556.
23. Guri AJ, Hontecillas R, Bassaganya-Riera J. Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration. Clin Nutr. 2010;29:824-831.
24. Kazi HA, Qian Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB. Saudi J Gastroenterol. 2009;15: 181-187.
25. Joo YE, Karrasch T, Mühlbauer M, et al. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signalling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One. 2009;4:e4562.
26. Fischbeck A, Leucht K, Frey-Wagner I, et al. Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis. Gut. 2011;60:55-65.
27. Hausmann M, Obermeier F, Paper DH, et al. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2007;148: 373-381.
28. Reddy D, Siegel CA, Sands BE, et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol. 2006;101: 1569-1573.
29. Crockett SD, Porter CQ, Martin CF, et al. Isotretinoin use and the risk of inflammatory bowel disease: A case-control study. Am J Gastroenterol. 2010;105:1986-1993.
30. Kim DJ, Kim KS, Song MY, et al. Delivery of IL-12p40 ameliorates DSSinduced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa. Clin Immunol. 2012;144:190-199.
31. Kristensen NN, Olsen J, Gad M, et al. Genome-wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis. 2008;14:75-87.